179 related articles for article (PubMed ID: 31309714)
21. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
Jensvoll H; Blix K; Brækkan SK; Hansen JB
PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
[TBL] [Abstract][Full Text] [Related]
22. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.
Sørensen HT; Horvath-Puho E; Pedersen L; Baron JA; Prandoni P
Lancet; 2007 Nov; 370(9601):1773-9. PubMed ID: 18037081
[TBL] [Abstract][Full Text] [Related]
24. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers D; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
Thromb Res; 2020 Jul; 191():148-150. PubMed ID: 32381264
[TBL] [Abstract][Full Text] [Related]
25. Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.
Corley AM; Sullivan MJ; Friedman SE; O'Rourke DJ; Palac RT; Gemignani AS
Am J Cardiol; 2019 Feb; 123(4):679-683. PubMed ID: 30528279
[TBL] [Abstract][Full Text] [Related]
26. Hematocrit and incidence of venous thromboembolism.
Folsom AR; Wang W; Parikh R; Lutsey PL; Beckman JD; Cushman M;
Res Pract Thromb Haemost; 2020 Mar; 4(3):422-428. PubMed ID: 32211576
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.
Liang RA; Høiland II; Ueland T; Aukrust P; Snir O; Hindberg K; Braekkan SK; Garred P; Mollnes TE; Hansen JB
J Thromb Haemost; 2019 Oct; 17(10):1661-1669. PubMed ID: 31220397
[TBL] [Abstract][Full Text] [Related]
28. Hematocrit and risk of venous thromboembolism in a general population. The Tromso study.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Haematologica; 2010 Feb; 95(2):270-5. PubMed ID: 19833630
[TBL] [Abstract][Full Text] [Related]
29. Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke.
Sundbøll J; Darvalics B; Horváth-Puhó E; Adelborg K; Laugesen K; Schmidt M; Henderson VW; Sørensen HT
J Thromb Haemost; 2018 Nov; 16(11):2175-2183. PubMed ID: 30179297
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
[TBL] [Abstract][Full Text] [Related]
31. Platelet count and the risk for thrombosis and death in the elderly.
van der Bom JG; Heckbert SR; Lumley T; Holmes CE; Cushman M; Folsom AR; Rosendaal FR; Psaty BM
J Thromb Haemost; 2009 Mar; 7(3):399-405. PubMed ID: 19143922
[TBL] [Abstract][Full Text] [Related]
32. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
[TBL] [Abstract][Full Text] [Related]
33. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis.
Sørensen HT; Horvath-Puho E; Lash TL; Christiansen CF; Pesavento R; Pedersen L; Baron JA; Prandoni P
Circulation; 2011 Sep; 124(13):1435-41. PubMed ID: 21900083
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism.
Takach Lapner S; Julian JA; Linkins LA; Bates S; Kearon C
Thromb Haemost; 2017 Oct; 117(10):1937-1943. PubMed ID: 28771280
[TBL] [Abstract][Full Text] [Related]
35. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
Thromb Res; 2020 Jul; 191():145-147. PubMed ID: 32291094
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
[TBL] [Abstract][Full Text] [Related]
37. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
38. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.
Donzé JD; Ridker PM; Finlayson SR; Bates DW
BMJ; 2014 Sep; 349():g5334. PubMed ID: 25199629
[TBL] [Abstract][Full Text] [Related]
39. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism.
Brenner B; Bikdeli B; Tzoran I; Madridano O; López-Reyes R; Suriñach JM; Blanco-Molina Á; Tufano A; Núñez JJL; Trujillo-Santos J; Monreal M;
Am J Med; 2018 Sep; 131(9):1095-1103. PubMed ID: 29807000
[TBL] [Abstract][Full Text] [Related]
40. Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study.
Nørgaard I; Nielsen SF; Nordestgaard BG
Clin Chem; 2016 Mar; 62(3):525-34. PubMed ID: 26797686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
